56 results
Page 2 of 3
8-K
EX-10.1
qnbtkb322wl8e f7v8t0
26 Sep 23
Signed term sheet providing for up to $75 Million in debt financing to be used for the acquisition
8:45am
8-K
EX-10.2
unawyc glepdvfx2u
26 Sep 23
Signed term sheet providing for up to $75 Million in debt financing to be used for the acquisition
8:45am
S-3/A
vz8g3q7ce01crjx
29 Aug 23
Shelf registration (amended)
4:15pm
S-3
ryqvnjasg6376yfqbp3
22 Aug 23
Shelf registration
4:15pm
424B4
xfnz cspa
25 Apr 23
Prospectus supplement with pricing info
4:15pm
10-K
9dgw1um3urwu04ga
31 Mar 23
Annual report
4:17pm
8-K
EX-99.1
bcv0skdnpyb
20 Dec 22
Sharps Technology Begins Manufacturing at its Hungary Facility for the Company’s Innovative Syringe Products
8:20am
8-K
EX-99.1
lrds qr4620ad
13 Dec 22
Sharps Technology and Nephron Pharmaceuticals Signs Distribution
8:45am
8-K
EX-99.1
6u22xmrtd6zpsvi0hc
10 Nov 22
Nephron Pharmaceuticals Corporation and Sharps Technology, Inc. Announce
4:06pm
8-K
EX-10.1
owx7wyees6lla372at
6 Oct 22
Departure of Directors or Certain Officers
4:30pm
8-K
EX-10.1
yv2qrz63
4 Oct 22
Entry into a Material Definitive Agreement
9:00am
8-K
EX-99.1
spu1d
14 Jul 22
Sharps Technology Completes Acquisition of Safegard Medical Syringe Manufacturing Facility
4:05pm
8-K
EX-99.1
2t1dnniqp 5jkz0iw125
8 Jun 22
Sharps Technology Announces Letter to Shareholders
4:10pm
10-Q
szmmvubuusg00c8saxqr
25 May 22
Quarterly report
5:29pm
8-K
EX-1.1
y65ow llbpmqb
19 Apr 22
Sharps Technology Announces Pricing of Initial Public Offering
4:17pm